Venture capitalists are funding quantum computing companies at record speeds, often without conducting the rigorous technical due diligence that was standard practice 15 years ago. The quantum sector has become a case study in how frontier technology investment has fundamentally changed, with private venture investment reaching $4.9 billion in 2025 against only $1.4 billion in actual market revenue.

What Changed in How Venture Firms Evaluate Deep Tech?

The shift reflects a dramatic split in venture capital markets. For most startups, raising capital has become slower and more difficult. The median time between a seed round and Series A funding stretched to 774 days in late 2024, compared to 420 days in late 2021, a roughly 84 percent increase. But for frontier deals in quantum computing and artificial intelligence, the opposite happened. Deals that once took months to close now close in days, and the technical review that investors once demanded has become nearly invisible from the outside.

Fifteen years ago, major investment banks would arrange sessions where domain experts in fields like cybersecurity would brief hedge funds and corporate investors on whether a company's claims actually worked. Those conversations were demanding and thorough. Today, those expert reviews have largely disappeared from frontier technology deals, replaced by a reliance on the reputation of lead investors and the names on a company's cap table.

Why Are Investors Moving So Fast on Quantum Deals?

Several structural forces are driving this acceleration. Venture funds raised record amounts in 2020, 2021, and 2022, then struggled to find companies they wanted to back at the prices founders expected. By the end of 2023, US venture funds had accumulated $311.6 billion in committed but uninvested capital, a record amount. Funds raised during that period typically have three to five year investment windows, after which uncalled capital must be returned to investors and management fees stop accruing. This creates intense pressure to deploy capital quickly.

A venture partner with $400 million to place before a deadline and limited partners demanding artificial intelligence exposure has one clear incentive: to be in the round. That partner has no incentive to spend three months reviewing the physics of a quantum computing startup.

Beyond deployment pressure, venture investors are also following each other into deals without conducting independent technical review. This herding behavior is well-documented in finance research. A manager whose reputation depends on being judged competent will follow the decisions of other managers and ignore private information that contradicts the crowd, because being wrong alongside others is read as bad luck, while being wrong alone is read as incompetence.

How Are Quantum Companies Raising Money Without Revenue?

The contrast between D-Wave Quantum and QuantumScape illustrates the current venture landscape. D-Wave, which has paying customers including Mastercard, Pfizer, and Siemens Healthineers, generated $24.6 million in revenue in fiscal 2025, a 178.5 percent increase from the previous year. Yet the company reported a net loss of $355.1 million and negative free cash flow of $75.8 million. Despite these losses, D-Wave has a market capitalization of $6.6 billion.

QuantumScape, by contrast, has zero revenue because its solid-state battery technology remains in prototype and testing phases. The company reported a net loss of $435.1 million in fiscal 2025 and negative free cash flow of $278.8 million. Yet it maintains a market capitalization of $3.0 billion, supported by partnerships with Volkswagen and Honda.

Both companies exemplify how frontier technology investment has decoupled from traditional financial metrics. Investors are betting on future breakthroughs rather than current performance, and they are making those bets with minimal technical scrutiny.

Steps to Understand the Risks in Quantum Venture Investing

• Examine the Revenue-to-Capital Ratio: Quantum raised $4.9 billion in private venture investment in 2025 against only $1.4 billion in actual market revenue, the widest gap among any sector. This disparity suggests investors are betting on technology that has not yet achieved commercial viability.
• Assess the Technical Review Process: Ask whether lead investors conducted independent technical due diligence or relied primarily on the reputation of other investors in the round. Deals that close in days rather than months typically skip rigorous physics or engineering review.
• Evaluate Cash Runway and Burn Rate: D-Wave is burning through roughly $37 million per quarter despite generating revenue, while QuantumScape is burning $278.8 million annually with no revenue. Companies with limited cash runway may face pressure to raise additional capital, which could dilute existing shareholders.

The venture capital industry has not publicly acknowledged this shift. Dakin Sloss, who runs Prime Movers Lab, a venture firm focused on breakthrough science, noted in 2022 that venture firms cannot reliably distinguish between a true breakthrough, a small iteration of existing technology, and pseudoscience that will never work. He attributed this to two decades of capital flowing to mobile apps, social media, software-as-a-service (SaaS), and fintech, sectors where technical expertise matters less than market timing and user adoption.

"Venture firms cannot tell whether a company has developed a true breakthrough, a small iteration of existing technology, or pseudoscience that will never work," Sloss explained.

Dakin Sloss, Prime Movers Lab

The remedy Sloss proposed was for venture firms to hire people who understand the underlying science alongside their traditional MBA-trained investors. There is no public evidence that many firms have done so.

For investors evaluating quantum computing companies, the absence of visible technical due diligence is itself a signal. When a deal closes in days and the lead investors' names are the primary justification for the valuation, the physics check has likely been skipped. Whether that represents a genuine oversight or a deliberate choice to rely on private technical review remains unclear, because the investors have not disclosed their process.